• University of Leeds Featured PhD Programmes
  • University of Bristol Featured PhD Programmes
  • Carlos III Health Institute Featured PhD Programmes
  • University of Mannheim Featured PhD Programmes
  • London School of Economics and Political Science Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Kent Featured PhD Programmes
King Abdullah University of Science and Technology (KAUST) Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Manchester Featured PhD Programmes

Stratification in Alzheimer’s disease

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Prof Bjourson
    Dr McClean
  • Application Deadline
    Applications accepted all year round

About This PhD Project

Project Description

Alzheimer’s disease is a devastating neurodegenerative condition characterised by the accumulation of
beta amyloid plaques, neurofibrillary tangles and neuronal and synaptic loss (Serrano-Pozo et al, 2011),
which results in reduced cognitive function and eventual loss of independence. The disease affects
approximately 850,000 people in the UK at an estimated cost of 26.3 billion annually (Alzheimer’s Society,
2014), representing a significant personal and economic burden. The incidence of Alzheimer’s disease is
set to quadruple by 2050 (Brookmeyer et al. 2007). Only by improving our understanding of the
pathogenesis of Alzheimer’s disease and designing new disease-modifying treatments will we be able to
work towards strategies to delay disease onset and progression.
Early onset Alzheimer’s disease (EOAD) is defined clinically as presenting before the age of 65 and most
inherited cases are considered to be due to mutations in amyloid precursor protein (APP), presenilin 1
(PSEN1), and presenilin 2 (PSEN2) genes (Bird, 2008). Late onset Alzheimer’s disease (LOAD) is a more
complex disorder, likely involving multiple susceptibility genes, of which APOE4 is most prevalent (Bird,
2008).

The purpose of this PhD project study is to stratify patients with different age of onset; 40-50, 50-60, 60-70
and 70-80 in order to determine if there are genetic, biochemical and environmental factors and comorbidities
associated with age of onset. Disease progression will be followed in order to determine if there
are shared features associated with the level of deterioration within and between patients with different age
of onset.

For more information please refer to the following site: http://www.science.ulster.ac.uk/gradschool/files/2016/01/B-Stratification-in-Alzheimer%E2%80%99s-disease.pdf
Share this page:

Cookie Policy    X